Forget Offices, Invest in Life Sciences Real Estate, Report Says
Spaces for pharmaceutical research and medical device development can generate cash flow, as well as offer downside protection, according to Willis Towers Watson.
Not a chance, says Fed’s Bullard, invoking history to slam alternate currencies to a dominant greenback.
These guys were among 15 who personally pocketed $23 billion from their investing scores, a Bloomberg tally shows.